4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3,4:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[34:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders | Patent Number 11753419

US 11753419 B2
Application Number17757212
Publication NumberUS 20230021717 A1
Pendency2 years, 9 months, 6 days
Filled DateDec 10, 2020
Priority DateDec 11, 2019
Publication DateJan 26, 2023
Expiration DateDec 10, 2039
Inventor/ApplicantsKimberly Vanover
Robert E Davis
Peng Li
Peng LI
Robert E DAVIS
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.